Single-use Bioprocessing Systems Market: Technological Advancements and Product Innovations to Catalyze Growth

Estimated reading time: 2 minutes

The single-use bioprocessing systems market is extremely competitive as the top five players accounted for a combined share of 95.2% share in 2015, finds Transparency Market Research (TMR). The top companies are Thermo Fisher Scientific, GE Healthcare, Pall Corporation, Merck KGaA, and Sartorius AG. The mammoth share held by large global biotechnology and pharmaceutical companies indicates that the threat of new entrants is moderate. Leading companies in the single-use bioprocessing systems market offer unique proprietary products leading to high barrier to entry, notes TMR. However over the forecast period, with the entry of several new players, the degree of competition in the market is projected to remain moderate-to-high.

The global single-use bioprocessing systems market was valued at US$2.3 bn in 2015. Rising at a CAGR of 11.1% from 2016 to 2024, the market is expected to reach US$5.9 bn by the end of the forecast period.

Asia Pacific Market to Provide Lucrative Growth Avenues

Geographically, Europe occupied the major share in 2016 and is projected to dominate the global single-use bioprocessing systems market through the forecast period. However, this regional market is likely to lose some of its share in the coming years. Meanwhile, the Asia Pacific market for single-use bioprocessing systems is anticipated to emerge as one of the most lucrative regional markets, expanding at 12.3% CAGR during 2016–2024.

On the basis of product, the single-use bioprocessing bags segment is expected to dominate the market and is projected to attain a significant share of 27.0% share by the end of 2024. The substantial growth of the bioprocessing bags segment can be attributed to their substantial demand for a variety of upstream and downstream applications. Bioprocessing bags are extensively used in processes such as mixing, storage, filtration, media preparation, and fermentation during the production of drug molecules, monoclonal antibodies, and vaccines.

Customization in Single-Use Bioprocessing Systems to Bolster Uptake

The growth of the single-use bioprocessing systems market is propelled by a wide gamut of biotechnological applications such as monoclonal antibody production, plant cell cultivation, patient specific cell therapies, and vaccine production. The surge in production of monoclonal antibodies in developed regions has translated for a substantial demand for single-use bioprocessing systems. Favorable regulations by various agencies such as the U.S. Food and Drug Administration (FDA) and extensive support from the European Union (EU) to boost the production of antibody therapeutics have catalyzed the growth of the single-use bioprocessing systems market.

The rising demand for customization in single-use bioprocessing systems is a crucial factor fueling the market growth. Increase in number of customer-specific customization requests tailored to specific needs has positively impacted the single-use bioprocessing systems market. Furthermore, the growing adoption of single-use bioprocessing technologies by several contract research organizations (CROs) is expected to boost the market through the forecast period.

However, technical constraints and several environmental concerns related to disposable of bags are key factors likely to hinder the market to an extent. Nevertheless, constant technological advancements in bioprocessing has led to innovative products that are cost-effective and significantly reduce product cross-contamination in various manufacturing processes. The elimination of clean-in-place (CIP) methods in many pharmaceutical plants has further catapulted the demand for single-use bioprocessing systems. This is expected to create exciting growth opportunities for market players.